Form 8-K - Current report:
SEC Accession No. 0001477932-25-002557
Filing Date
2025-04-09
Accepted
2025-04-09 16:01:13
Documents
15
Period of Report
2025-04-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K thct_8k.htm   iXBRL 8-K 19521
  Complete submission text file 0001477932-25-002557.txt   132620

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA thct-20250402.xsd EX-101.SCH 5874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20250402_lab.xml EX-101.LAB 13171
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20250402_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20250402_pre.xml EX-101.PRE 8249
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20250402_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT thct_8k_htm.xml XML 3542
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

EIN.: 260164981 | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-55994 | Film No.: 25825171
SIC: 3523 Farm Machinery & Equipment
(CF Office: 06 Technology)